Page 1 of Clinical Trials for Interferon beta 1a, 153 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects
Last Updated: February 10, 2011
Condition(s): Healthy
2
Completed
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
Last Updated: December 22, 2011
Condition(s): Relapsing-remitting Multiple Sclerosis
3
Completed
Immunogenicity and Safety Study of Serum-Free Avonex
Last Updated: June 5, 2009
Condition(s): Multiple Sclerosis
4
Completed
Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)
Last Updated: November 3, 2011
Condition(s): Multiple Sclerosis
5
Completed
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Last Updated: January 26, 2010
Condition(s): Multiple Sclerosis
6
Completed
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Last Updated: March 7, 2012
Condition(s): Alzheimer's Disease
7
Completed
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
Last Updated: December 11, 2007
Condition(s): Relapsing Remitting Multiple Sclerosis
8
Completed
A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers
Last Updated: June 3, 2009
Condition(s): Multiple Sclerosis
9
Recruiting
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Last Updated: May 21, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
10
Recruiting
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Last Updated: May 21, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
11
Completed
An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis
Last Updated: June 10, 2010
Condition(s): Multiple Sclerosis
12
Completed
An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone
Last Updated: June 10, 2010
Condition(s): Relapsing-Remitting Multiple Sclerosis
13
Active, not recruiting
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
Last Updated: September 30, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
14
Completed
Open-Label Safety Extension Study of Avonex
Last Updated: June 5, 2009
Condition(s): Multiple Sclerosis
15
Recruiting
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.
Last Updated: August 8, 2011
Condition(s): Multiple Sclerosis
16
Active, not recruiting
Combination Therapy Using Cellcept and Rebif in RRMS
Last Updated: October 17, 2011
Condition(s): Multiple Sclerosis
17
Completed
A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)
Last Updated: June 10, 2010
Condition(s): Relapsing-Remitting Multiple Sclerosis
18
Recruiting
Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment
Last Updated: January 12, 2012
Condition(s): Relapsing-Remitting Multiple Sclerosis
19
Completed
Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers
Last Updated: May 10, 2012
Condition(s): Multiple Sclerosis
20
Completed
Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe
Last Updated: June 5, 2009
Condition(s): Multiple Sclerosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Interferon+beta+1a

Page 1 of Clinical Trials for Interferon beta 1a, 153 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About